Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson's disease

被引：0
|
作者：
Artaud, F.
Lee, P. C.
Vidailhet, M.
Corvol, J. C.
Elbaz, A.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1795
引用
收藏
页码：S738 / S738
页数：1
相关论文
共 50 条
  • [31] Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in Parkinson's Disease
    Cicero, Calogero Edoardo
    Terravecchia, Claudio
    Tabbi, Silvia
    Garofalo, Rossella
    Luca, Antonina
    Mostile, Giovanni
    Donzuso, Giulia
    Contrafatto, Donatella
    Zappia, Mario
    Nicoletti, Alessandra
    JOURNAL OF NEUROLOGY, 2025, 272 (01)
  • [32] Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson’s disease
    Alex Tsui
    Ole Isacson
    Journal of Neurology, 2011, 258
  • [33] Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease
    Tsui, Alex
    Isacson, Ole
    JOURNAL OF NEUROLOGY, 2011, 258 (08) : 1393 - 1405
  • [34] Safe and tolerable switching from oral dopaminergic agonists to transdermal rotigotine in Parkinson's disease
    LeWitt, P.
    Boroojerdi, B.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S110 - S111
  • [35] Parkinson's disease and dopaminergic neurons
    Neural Regeneration Research, 2012, (05) : 368 - 368
  • [36] Is there a coupling between dopaminergic function and oxidative metabolism in Parkinson's disease?
    Brownell, AL
    Chen, YI
    Canales, K
    Owen, C
    Livni, E
    Cicchetti, F
    Sanchec-Pernaute, R
    Isacson, O
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 14P - 14P
  • [37] Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease
    Hinkle, Jared T.
    Mills, Kelly A.
    Perepezko, Kate
    Pontone, Gregory M.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2022, 35 (03) : 353 - 362
  • [38] The use of dopamine agonists in very elderly patients with Parkinson's disease
    Shulman, LM
    Minagar, A
    Rabinstein, A
    Weiner, WJ
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 497 - 498
  • [39] Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease
    Schapira, AHV
    Olanow, CW
    ANNALS OF NEUROLOGY, 2003, 53 : S149 - S157
  • [40] The use of dopamine agonists in very elderly patients with Parkinson's disease
    Shulman, LM
    Minagar, A
    Rabinstein, A
    Weiner, WJ
    MOVEMENT DISORDERS, 2000, 15 (04) : 664 - 668
12345